Booth Kalmbach, CEO, Entigral Systems, Inc.
Mr. Kalmbach co-founded Entigral in 2003, and has directed the architecture, development, and product marketing of TraxWare®, Entigral’s groundbreaking sensor automation platform. Mr. Kalmbach is a successful serial software entrepreneur who has founded, managed, funded, and exited several software ventures including Virtus Corporation (CEO & Co-founder; 3D modeling and gaming; acquired in 1996 by Ubisoft Entertainment S.A.), Q+E Software Inc. (VP Marketing; database access; acquired in 1994 by Intersolv Inc.), ProMedex Inc. (CTO & Co-founder; web-based disease management; acquired in 2000 by InLight Inc.), and Coactive Systems Corporation (CEO & Founder; cloud-based contact center software; acquired in 2003 by First Consulting Group Inc.). Mr. Kalmbach holds a U.S. patent in distributed computing from his career as an IBM Scientist. He received a B.E. in Electrical Engineering from Vanderbilt University, Cum Laude, and an M.B.A. from Duke University Fuqua School of Business, where he was a Fuqua Honors Scholar.
Follow Entigral on Twitter, Facebook, and LinkedIn
Follow Booth on Twitter and LinkedIn
Mark Gemberling, Vice President of Sales and Marketing, Entigral Systems, Inc.
Mr. Gemberling is an experienced sales and marketing executive with over 25 years of experience in the technology industries. He has provided transformational leadership in the areas of strategic and tactical planning, sales process improvement, and organizational development. He comes to us from Belden where he was the Vice President of Sales, Americas. While there, he developed and implemented strategic plans to generate demand for Belden’s products to end users through direct sales, contractors, consultants, and distributors. Prior to Belden, he held several key leadership roles at GE Healthcare including being the National Sales Manager for Systems &Wireless where he leveraged technology and accessibility of data to improve patient and clinical workflow. He holds a BS in Biomedical Engineering from Marquette University.
Follow Entigral on Twitter, Facebook, and LinkedIn
Follow Mark on LinkedIn
David A. Houghton, Director, Bright Wolf
David has over 25 years experience working at the intersection of technology, pharmaceuticals, healthcare, and performance improvement in a variety of strategic planning, management, operations, business development and marketing posts. Mr. Houghton currently leads the sales and business development activities as Director for Bright Wolf, a software company developing and deploying IoT solutions. Before joining Bright Wolf, Mr. Houghton was the CEO of Veedims, leading the commercialization of a novel technology targeting the real time M2M automation space. The prior two years were spent consulting to Verizon, shaping and executing their healthcare vertical and identity solution strategies. Before Verizon, Mr. Houghton managed and led the sale of Systems Pathology Company, an innovative software start up to Charles River Laboratories. As a Vice President for SAIC, David initiated and led the Commercial Life Sciences Practice for 9 years. Mr. Houghton was Vice President, Business Development for Axios Data Analysis Systems Corp – a high performance software analytics firm targeting the Healthcare marketplace. Mr. Houghton held senior positions at Pfizer Inc, in the Global Development Organization where he was responsible for strategic planning and operations. His field sales and systems experience spans 13 years and includes assignments with Sun Microsystems and Unisys Corporation. Mr. Houghton holds a BA in Economics from Villanova University.
Follow Bright Wolf on Twitter, Facebook, and LinkedIn
Follow David on LinkedIn
